Study of Cannabidiol for Drug-Resistant Epilepsies

Status No longer available

Clinical Trial Summary

The purpose of this study is to determine if cannabidiol is safe and effective at different doses as an additional treatment for pediatric drug-resistant epilepsy. Pure cannabidiol has potentially therapeutic properties, such as anti-convulsant effects, that may reduce seizure frequency. There are only a few open label studies that have demonstrated the safety and tolerance of cannabiodiol in both adult and pediatric epileptic populations--these studies were performed either retrospectively or with varying cannabidiol preparations. There are no well-documented studies and completely analyzed data for pediatric epileptic patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03014440
Study type	Expanded Access
Source	Children's Hospital of Philadelphia
Contact
Status	No longer available
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04378075` - A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy	Phase 2/Phase 3
Recruiting	`NCT05928598` - Goals for Epilepsy Clinic Visits Trial	N/A
Recruiting	`NCT05539287` - Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy	Phase 2
Not yet recruiting	`NCT04601974` - Lentiviral Gene Therapy for Epilepsy	Phase 1/Phase 2
Completed	`NCT02982824` - Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy	N/A
Recruiting	`NCT05485558` - the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy	Phase 2
Not yet recruiting	`NCT04553354` - Cortical Resections in Drug Resistant Epilepsy
Recruiting	`NCT04999046` - NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy	N/A
Recruiting	`NCT04714996` - Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy	Phase 2
Recruiting	`NCT04839601` - RNS System RESPONSE Study	N/A
Recruiting	`NCT06059157` - Epileptogenic Network Visualisation With Advanced MRI	N/A
Recruiting	`NCT05947656` - Evaluation of the NaviFUS System in Drug Resistant Epilepsy	N/A
Recruiting	`NCT05393518` - Electroclinical Correlation of Anxiety	N/A
Not yet recruiting	`NCT05555537` - MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy
Completed	`NCT03419000` - Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY	N/A
Enrolling by invitation	`NCT06341075` - Real-World Study of Magnetic Resonance-guided Laser Interstitial Thermal Therapy for Drug-resistant Epilepsy	N/A
Not yet recruiting	`NCT05527093` - Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy	N/A
Recruiting	`NCT05697614` - The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children	Phase 4
Recruiting	`NCT06309251` - Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Not yet recruiting	`NCT06340802` - A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl	N/A